SCHEMBL218183

SCHEMBL218183

Cc1cccc(=O)[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21777149 0.85 FKBP5 (0.64)
SCHEMBL29848931 0.82
Trifluoroacetic Acid SCHEMBL29437766 0.82 MMP1 (0.38)
SCHEMBL14080856 0.74 CYP1A2 (0.44)
SCHEMBL5393702 0.72
SCHEMBL8535240 0.71 NOTUM (0.68)
SCHEMBL2625317 0.67 NOTUM (0.40)
SCHEMBL179270 0.67 MMP1 (0.44)
SCHEMBL2632725 0.67
SCHEMBL17459262 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 627 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250388543-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-12-25 US claimed
CN-116854631-B 4-Aryl-2-pyridone compound and preparation method thereof 安徽中医药大学 2025-04-15 CN claimed
EP-4414037-A2 MORPHINAN DERIVATIVES FOR THE TREATMENT OF OPIOID DELTA RECEPTOR AGONIST-RELATED DISEASES Nippon Chemiphar Co., Ltd. (JP) 2024-08-14 EP claimed
EP-4396191-A1 COMPOUNDS USEFUL IN MODULATION OF AHR SIGNALLING JAGUAHR THERAPEUTICS PTE LTD (SG) 2024-07-10 EP claimed
EP-3513792-B9 MORPHINAN DERIVATIVES FOR THE TREATMENT OF OPIOID DELTA RECEPTOR AGONIST-RELATED DISEASES NIPPON CHEMIPHAR CO (JP) 2024-07-10 EP claimed
US-20240156796-A1 PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF STRESS-RELATED DISORDERS TOKYO UNIVERSITY OF SCIENCE FOUNDATION (JP) 2024-05-16 US claimed
EP-3513792-B1 MORPHINAN DERIVATIVES FOR THE TREATMENT OF OPIOID DELTA RECEPTOR AGONIST-RELATED DISEASES NIPPON CHEMIPHAR CO (JP) 2024-03-27 EP claimed
EP-4299074-A1 PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF STRESS-RELATED DISORDERS TOKYO UNIVERSITY OF SCIENCE FOUNDATION (JP) 2024-01-03 EP claimed
WO-2023033740-A9 COMPOUNDS USEFUL IN MODULATION OF AHR SIGNALLING JAGUAHR THERAPEUTICS PTE LTD (SG) 2023-12-28 WO claimed
CN-117122598-A Use of morphinan derivatives in the treatment of opioid delta receptor agonist-related diseases 日本化学药品株式会社 2023-11-28 CN claimed
EP-3157573-A2 ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF Moderna Therapeutics, Inc. (US) 2017-04-26 EP claimed
WO-2015196128-A2 ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF MODERNA THERAPEUTICS, INC. (US) 2015-12-23 WO claimed
EP-2320891-A1 BUTYRYLCHOLINESTERASE LIGANDS AS DIAGNOSTIC TOOLS AND TREATMENT FOR DESEASES OF THE NERVOUS SYSTEM Treventis Corporation (US) 2011-05-18 EP claimed
WO-2010025368-A1 BUTYRYLCHOLINESTERASE LIGANDS AS DIAGNOSTIC TOOLS AND TREATMENT FOR DESEASES OF THE NERVOUS SYSTEM TREVENTIS CORPORATION (US) 2010-03-04 WO claimed
EP-1490064-A1 SUBSTITUTED PYRIDINONES AS MODULATORS OF P38 MAP KINASE Pharmacia Corporation (US) 2004-12-29 EP claimed
WO-2003068230-A1 SUBSTITUTED PYRIDINONES AS MODULATORS OF P38 MAP KINASE PHARMACIA CORPORATION (US) 2003-08-21 WO claimed
EP-0145068-B1 PROCESS FOR THE PREPARATION OF 2-PYRIDONE STAMICARBON B.V. (NL) 1987-10-07 EP claimed
EP-0123362-B1 PROCESS FOR THE PREPARATION OF 6-METHYLPYRIDONE-2 STAMICARBON B.V. (NL) 1987-08-05 EP claimed
US-4639525-A Process for the preparation of pyridone-2 by demethylation STAMICARBON B.V. (NL) 1987-01-27 US claimed
EP-0145068-A2 Process for the preparation of 2-pyridone STAMICARBON B.V. (NL) 1985-06-19 EP claimed